221 related articles for article (PubMed ID: 19076986)
1. Moclobemide monotherapy vs. combined therapy with valproic acid or carbamazepine in depressive patients: a pharmacokinetic interaction study.
Rakic Ignjatovic A; Miljkovic B; Todorovic D; Timotijevic I; Pokrajac M
Br J Clin Pharmacol; 2009 Feb; 67(2):199-208. PubMed ID: 19076986
[TBL] [Abstract][Full Text] [Related]
2. Carbamazepine but not valproate induces bupropion metabolism.
Ketter TA; Jenkins JB; Schroeder DH; Pazzaglia PJ; Marangell LB; George MS; Callahan AM; Hinton ML; Chao J; Post RM
J Clin Psychopharmacol; 1995 Oct; 15(5):327-33. PubMed ID: 8830063
[TBL] [Abstract][Full Text] [Related]
3. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder.
Vasudev K; Goswami U; Kohli K
Psychopharmacology (Berl); 2000 May; 150(1):15-23. PubMed ID: 10867972
[TBL] [Abstract][Full Text] [Related]
4. Predictability of individualized dosage regimens of carbamazepine and valproate mono- and combination therapy.
Bondareva IB; Jelliffe RW; Andreeva OV; Bondareva KI
J Clin Pharm Ther; 2011 Oct; 36(5):625-36. PubMed ID: 21062333
[TBL] [Abstract][Full Text] [Related]
5. Influence of carbamazepine-10,11-epoxide on the serum level of valproic acid in epileptic patients on combined treatment with carbamazepine and valproic acid.
Minkova GD; Getova DP
Folia Med (Plovdiv); 2000; 42(3):16-9. PubMed ID: 11347330
[TBL] [Abstract][Full Text] [Related]
6. Lack of interaction of gabapentin with carbamazepine or valproate.
Radulovic LL; Wilder BJ; Leppik IE; Bockbrader HN; Chang T; Posvar EL; Sedman AJ; Uthman BM; Erdman GR
Epilepsia; 1994; 35(1):155-61. PubMed ID: 8112239
[TBL] [Abstract][Full Text] [Related]
7. [Effects of carbamazepine on plasma concentrations of valproic acid and its toxic metabolite in epileptic patients].
Chen ZJ; Wang XD; Zhou LM; Fang ZY; Wang HS; Li JL; Zhou JQ; Huang HB; Huang M
Yao Xue Xue Bao; 2014 Apr; 49(4):530-4. PubMed ID: 24974473
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial comparing lithium plus valproic acid versus lithium plus carbamazepine in young patients with type 1 bipolar disorder: the LICAVAL study.
Missio G; Moreno DH; Demetrio FN; Soeiro-de-Souza MG; Dos Santos Fernandes F; Barros VB; Moreno RA
Trials; 2019 Oct; 20(1):608. PubMed ID: 31655626
[TBL] [Abstract][Full Text] [Related]
9. Variability and clinical relevance of the interaction between sodium valproate and carbamazepine in epileptic patients.
McKee PJ; Blacklaw J; Butler E; Gillham RA; Brodie MJ
Epilepsy Res; 1992 May; 11(3):193-8. PubMed ID: 1396534
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy.
Mimrod D; Specchio LM; Britzi M; Perucca E; Specchio N; La Neve A; Soback S; Levy RH; Gatti G; Doose DR; Maryanoff BE; Bialer M
Epilepsia; 2005 Jul; 46(7):1046-54. PubMed ID: 16026556
[TBL] [Abstract][Full Text] [Related]
11. Studies on the pharmacokinetics of total and free valproate in mono- and bitherapy with carbamazepine in epileptic children and adolescents.
Steinborn B; Galas-Zgorzalewicz B
Folia Neuropathol; 2002; 40(2):97-100. PubMed ID: 12230261
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interactions of carbamazepine with some antiepileptic drugs during epilepsy treatment in children and adolescents.
Steinborn B
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():9-15. PubMed ID: 16119616
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid-carbamazepine interaction: is valproic acid a selective inhibitor of epoxide hydrolase?
Svinarov DA; Pippenger CE
Ther Drug Monit; 1995 Jun; 17(3):217-20. PubMed ID: 7624916
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetic modeling of steady state clearance of carbamazepine and its epoxide metabolite from sparse routine clinical data.
Jiao Z; Shi XJ; Zhao ZG; Zhong MK
J Clin Pharm Ther; 2004 Jun; 29(3):247-56. PubMed ID: 15153086
[TBL] [Abstract][Full Text] [Related]
15. Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy.
Ramsay RE; McManus DQ; Guterman A; Briggle TV; Vazquez D; Perchalski R; Yost RA; Wong P
Ther Drug Monit; 1990 May; 12(3):235-41. PubMed ID: 2112276
[TBL] [Abstract][Full Text] [Related]
16. The effect of carbamazepine on valproic acid disposition in adult volunteers.
Panesar SK; Orr JM; Farrell K; Burton RW; Kassahun K; Abbott FS
Br J Clin Pharmacol; 1989 Mar; 27(3):323-8. PubMed ID: 2497766
[TBL] [Abstract][Full Text] [Related]
17. Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
Nasrallah HA; Ketter TA; Kalali AH
J Affect Disord; 2006 Oct; 95(1-3):69-78. PubMed ID: 16780960
[TBL] [Abstract][Full Text] [Related]
18. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT
Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Pharmacokinetic Interactions With Eslicarbazepine Acetate Versus Oxcarbazepine and Carbamazepine in Clinical Practice.
Johannessen Landmark C; Svendsen T; Dinarevic J; Kufaas RF; Reimers A; Brodtkorb E; Baftiu A; Burns ML; Johannessen SI
Ther Drug Monit; 2016 Aug; 38(4):499-505. PubMed ID: 27414974
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.
Pohlmann-Eden B; Marson AG; Noack-Rink M; Ramirez F; Tofighy A; Werhahn KJ; Wild I; Trinka E
BMC Neurol; 2016 Aug; 16(1):149. PubMed ID: 27552848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
